By destabilizing HIF1α, SMURF2 disrupts the hypoxic adaptation mechanisms of cancer cells, thereby reducing their survival advantage and possibly enhancing the efficacy of existing treatments (13). The gene discussed is SMURF2; the disease is cancer.